Country: Նոր Զելանդիա
language: անգլերեն
source: Medsafe (Medicines Safety Authority)
Clindamycin hydrochloride 162.87mg equivalent to clindamycin 150 mg;
Douglas Pharmaceuticals Limited
Clindamycin hydrochloride 162.87 mg (equivalent to clindamycin 150 mg)
150 mg
Capsule
Active: Clindamycin hydrochloride 162.87mg equivalent to clindamycin 150 mg Excipient: Gelatin Lactose monohydrate Magnesium stearate Maize starch Opacode black S-1-277002 Purified talc Titanium dioxide
Blister pack, PVC/Alu, 24 capsules
Prescription
Prescription
Chongqing Carelife Pharmaceutical Co Ltd
Clindamycin hydrochloride has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: · Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. · Lower respiratory infections including bronchitis, pneumonia, emphysema and lung abscess. · Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections. For specific skin and soft tissue infections like erysipelas and paronychia (panaritium), it would seem logical that these conditions would respond very well to clindamycin therapy. · Bone and joint infections including osteomyelitis and septic arthritis. · Pelvic infections including endometritis, cellulitis, vaginal cuff infection tubo-ovarian abscesses salpingitis and pelvic inflammatory disease when given in conjunction with an antibiotic of appropriate gram negative aerobic spectrum. In cases of cervicitis due to Chlamydia trachomatis, mono therapy with clindamycin has been shown to be effective in eradicating the organism. · Intra-abdominal infections including peritonitis and abdominal abscess when given in conjunction with an antibiotic of appropriate gram negative aerobic spectrum. · Septicemia and endocarditis - the effectiveness of clindamycin in the treatment of selected cases of endocarditis has been documented when clindamycin is determined to be bactericidal to the infecting organism by in vitro testing of appropriate achievable serum concentrations. · Dental infections such as periodontal abscess and periodontitis. · As an alternative therapy when used in combination with quinine or amodiaquine for the treatment of multi-drug resistant Plasmodium falciparum infection.
Package - Contents - Shelf Life: Blister pack, PVC/Alu - 16 capsules - 24 months from date of manufacture stored at or below 25°C protect from light - Blister pack, PVC/Alu - 24 capsules - 24 months from date of manufacture stored at or below 25°C protect from light - Blister pack, PVC/Alu - 100 capsules - 24 months from date of manufacture stored at or below 25°C protect from light
2013-02-27
CONSUMER MEDICINE INFORMATION TOPICIL _Clindamycin hydrochloride _ 150 mg Capsule WHAT IS IN THIS LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TAKING TOPICIL. This leaflet answers some common questions about Topicil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Topicil against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT TOPICIL IS USED FOR Topicil contains clindamycin, which belongs to a group of medicines called antibiotics. Antibiotics are used to treat infections. Topicil is used to treat bacterial infections in different parts of the body. It works by killing or stopping the growth of the bacteria causing your infection. Your doctor may have prescribed Topicil for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY TOPICIL HAS BEEN PRESCRIBED FOR YOU. BEFORE YOU TAKE TOPICIL _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE TOPICIL IF YOU HAVE AN ALLERGY TO: • any medicine containing clindamycin or lincomycin. • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • difficulty in breathing or wheezing • shortness of breath. • swelling of the face, tongue, lips, or other parts of the body. • hives on the skin, rash, or itching. DO NOT TAKE TOPICIL IF: DO NOT TAKE IT AFTER THE EXPIRY DATE (EXP) PRINTED ON THE BACK. If you take it after the expiry date has passed, it may not work as well. DO NOT TAKE IT IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. IF YOU ARE NOT SURE WHETHER YOU SHOULD START TAKING TOPICIL, TALK TO YOUR DOCTOR. _BEFORE YOU START TO TAKE IT _ _ _ TELL YOUR DOCTOR IF: 1. YOU HAVE ALLERGIES TO: • any other medicines. • any other substances, such as foods, preservatives or dye read_full_document
1 | P a g e NEW ZEALAND DATA SHEET 1. PRODUCT NAME Topicil 150 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Topicil Capsule contains clindamycin hydrochloride 162.87 mg (equivalent to clindamycin 150 mg). EXCIPIENT(S) WITH KNOWN EFFECT Topicil Capsules contain lactose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Topicil Capsules are white/white hard gelatin capsules with a marking of ‘CLIN 150’ on the capsule body. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Clindamycin hydrochloride has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram-positive bacteria such as streptococci, staphylococci and pneumococci: • Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. • Lower respiratory infections including bronchitis, pneumonia, emphysema and lung abscess. • Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections. For specific skin and soft tissue infections like erysipelas and paronychia (panaritium), it would seem logical that these conditions would respond very well to clindamycin therapy. • Bone and joint infections including osteomyelitis and septic arthritis. • Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease when given in conjunction with an antibiotic of appropriate gram-negative aerobic spectrum. In cases of cervicitis due to _Chlamydia trachomatis_, monotherapy with clindamycin has been shown to be effective in eradicating the organism. • Intra-abdominal infections including peritonitis and abdominal abscess when given in conjunction with an antibiotic of appropriate gram-negative aerobic spectrum. 2 | P a g e • Septicaemia and endocarditis - the effectiveness of clindamycin in the treatment of selected cases of endocarditis has been do read_full_document